FTRE(Fortrea Holdings Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $3.06B | $2.84B | $2.84B | $2.70B | $2.72B |
| 毛利润 | — | — | — | — | — |
| 营业利润 | $114.30M | $187.10M | $32.00M | −$161.90M | −$872.60M |
| 净利润 | $98.00M | $186.20M | −$25.20M | −$328.50M | −$986.20M |
| 经营现金流 | $169.80M | $82.70M | $168.40M | $262.80M | $113.50M |
| 自由现金流 | $143.30M | $28.30M | $128.10M | $237.30M | $88.30M |
| 摊薄每股收益 | $1.10 | $2.09 | $-0.29 | $-3.67 | $-10.81 |